Home NDC 63629-7433-2 Rizatriptan Benzoate
Product NDC 63629-7433
Requested package NDC 63629-7433-2
11-digit product format 636297433
Labeler code 63629
Product ID 63629-7433_440c4581-1f01-4ae7-b627-cb236ef59516
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Rizatriptan Benzoate
Dosage form TABLET
Route ORAL
Labeler Bryant Ranch Prepack
Application ANDA204339
Marketing category ANDA
Marketing start 2016-07-22
Marketing end 0000-00-00
Substance RIZATRIPTAN BENZOATE
Active strength 10 mg/1
Pharmacologic classes Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 16 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…2020-06-10 20:45 UTC · source 2020-06-10 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A204339-001 RIZATRIPTAN BENZOATE RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 A204339-002 RIZATRIPTAN BENZOATE RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL 2013-07-01 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL 2013-07-01 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL AB 2013-07-01 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL AB 2013-07-01 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL AB 2013-07-01 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL AB 2013-07-01 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL AB 2013-07-01 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL AB 2013-07-01 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL AB 2013-07-01 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL AB 2013-07-01 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A204339-001 RIZATRIPTAN BENZOATE EQ 5MG BASE TABLET / ORAL AB 2013-07-01 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A204339-002 RIZATRIPTAN BENZOATE EQ 10MG BASE TABLET / ORAL AB 2013-07-01 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 52 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 63629-7433-1 2024-01-30 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-2 2024-01-30 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-3 2024-01-30 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-4 2024-01-30 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-5 2024-01-30 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-6 2024-01-30 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-7 2024-01-30 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-1 2020-10-28 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-2 2020-10-28 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-3 2020-10-28 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-4 2020-10-28 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-5 2020-10-28 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-1 2020-01-31 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-2 2020-01-31 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-3 2020-01-31 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-4 2020-01-31 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998 63629-7433-5 2020-01-31 These highlights do not include all the information needed to use rizatriptan benzoate tablets safely and effectively. See full prescribing information for rizatriptan benzoate tablets. Rizatriptan Benzoate Tablets, for oral use Initial U.S. Approval: 1998
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63629-7433-1 Rizatriptan Benzoate 10 in 1 BOTTLE TABLET 10 7 63629-7433-2 Rizatriptan Benzoate 6 in 1 BOTTLE TABLET 6 7 63629-7433-3 Rizatriptan Benzoate 90 in 1 BOTTLE TABLET 90 7 63629-7433-4 Rizatriptan Benzoate 9 in 1 BOTTLE TABLET 9 7 63629-7433-5 Rizatriptan Benzoate 30 in 1 BOTTLE TABLET 30 7 63629-7433-6 Rizatriptan Benzoate 18 in 1 BOTTLE TABLET 18 7 63629-7433-7 Rizatriptan Benzoate 12 in 1 BOTTLE TABLET 12 7
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63629-7433 RIZATRIPTAN BENZOATE TABLET [BRYANT RANCH PREPACK] 7 Legacy NDC, 7 package rows 20220115_32094145-be64-4f14-ace7-b29c9b051daf.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63629-7433-2 63629743302 6 TABLET in 1 BOTTLE (63629-7433-2) 6 tablet 2021-12-22 0000-00-00 No No Current